Researchers track Body's response to lifesaving fat disorder drug
Disease control
Completed
This study monitored 11 patients with generalized lipodystrophy, a rare disorder causing severe fat loss and metabolic problems, who were starting daily metreleptin injections. The main goal was to see if their immune systems developed antibodies against the drug over three years…
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC